Single Dose Pharmacokinetic (PK) Study

Clinical trial NCT03109756 · COMPLETED

Trial details

NCT number: NCT03109756
Sponsor: Healx AI
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Angelman Syndrome Fragile X Syndrome

Start date: 2017-04-03
Primary completion: 2017-11-28
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.